Early progressive disease within 2 years in isocitrate dehydrogenase (IDH)–mutant astrocytoma may indicate radiation necrosis
Radiation necrosis should be considered in cases showing early progression of isocitrate dehydrogenase-mutant astrocytoma, and a second surgery should be performed to confirm true recurrence or radiation necrosis. Astrocytomas with telomerase reverse-transcriptase promoter mutations may relapse relatively early and should be followed up with caution.
Authors
- Akihiko Yoshida (ORCID: https://orcid.org/0000-0002-3373-0099)
- Yuko Kubo (ORCID: https://orcid.org/0000-0002-4116-3370)
- Mai Honda‐Kitahara
- Hirokazu Sugino (ORCID: https://orcid.org/0000-0002-8848-9415)
- Tomohiro Hosoya
- Kenkichi Masutomi (ORCID: https://orcid.org/0000-0002-6739-4257)
- Shunsuke Yanagisawa (ORCID: https://orcid.org/0000-0002-6507-0427)
- Kaishi Satomi (ORCID: https://orcid.org/0000-0001-7611-5822)
- Hiroshi Igaki (ORCID: https://orcid.org/0000-0001-7817-624X)
- Yasuji Miyakita (ORCID: https://orcid.org/0000-0001-6701-2549)
- Makoto Ohno (ORCID: https://orcid.org/0000-0001-8031-4306)
- Akihide Kondo (ORCID: https://orcid.org/0000-0003-1729-4490)
- Yukie Ozeki (ORCID: https://orcid.org/0000-0002-2419-9398)
- Masamichi Takahashi (ORCID: https://orcid.org/0000-0001-8792-1993)
- Koichi Ichimura (ORCID: https://orcid.org/0000-0002-3851-2349)
- Yoshitaka Narita (ORCID: https://orcid.org/0000-0003-4303-6006)
- Tomoyuki Nakano (ORCID: https://orcid.org/0000-0003-0933-1714)
- Hiromichi Suzuki (ORCID: https://orcid.org/0000-0002-8858-0294)
- Miu Kikuchi
Institutions
- Tokai University (JP)
- Kyorin University (JP)
- Juntendo University (JP)
- National Cancer Center (US)
- Tokai University Hospital (JP)
- Saitama Cancer Center (JP)
- National Cancer Center Hospital East (JP)
- Tokyo National Hospital (JP)
- National Cancer Research Institute (GB)
Publication Details
- Journal
- Japanese Journal of Clinical Oncology
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1093/jjco/hyae151
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development